Multi-Strain 50
Natural health product licensed in Canada
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80045778
- Status
- Active licence
- Licence date
- 25 October 2013
- Revision date
- 8 March 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lacticaseibacillus rhamnosus Source : HA-111 | 9 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : En entier | 9 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : HA-116 | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : HA-135 | 11 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 11 Milliards d'UFC | Not calculated |
| Ligilactobacillus Salivarius Source : Cellule entière | 6.5 Milliards d'UFC | Not calculated |
| Ligilactobacillus Salivarius Source : HA-118 | 6.5 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Cellule entière | 7.5 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : HA-119 | 7.5 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : HA-132 | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
2-O-glucoside de l'acide ascorbique, Hypromellose, Cellulose en poudre, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
Probiotics that temporarily modify gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have nausea, fever, vomitting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (diarrhea) occur, worsen or persist beyond 3 days, discontinue use and consult a health care practitioner.
- Contre-indications
If you have an immune compromised condition (AIDS, lymphoma, undergoing long-term corticosteriod treatment) do not use this product. This product may have come in contact with milk. Do not use if you have a milk allergy.
Source
Official Health Canada record, licence 80045778
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.